A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
about
TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life.Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvantAg85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune ResponsesDesign and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.Update on Chlamydia trachomatis Vaccinology.Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.An overview of adjuvant formulations and delivery systems.Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists.The yin and yang of human Beta-defensins in health and diseaseChlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection.Crosstalk of dynamic functional modules in lung development of rhesus macaques.Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.The M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860
Q34314450-3866545F-8BC4-4A81-8E2B-7F79E7C6C24CQ36020045-37F471E4-E996-4F2D-83DA-87153F34057BQ36811968-3F009915-11C6-425E-93CD-AFFADAD912D0Q37198471-4B8C9071-AA58-4BD7-AABD-88360D54AFA1Q37293872-12B6BA70-E45D-455E-BA74-E42649CE240CQ37352073-0AD02317-F10A-48E9-B75F-FA6F2D2782DAQ37624678-64B4E97F-78E4-4BC9-AE58-4096A0BFE967Q37662675-81D3A86A-BF8A-4323-A430-859F5E8D94DDQ37834874-64FB66B2-8FC9-45E0-9755-6E159468E14EQ37848511-CF537912-2F4C-4735-AFB8-FCD9B24D16C8Q38124064-A0D4ED6A-9A08-47A4-A8B2-A4B0C4F054A4Q38126953-E01EF62C-698C-488E-9D04-17F7C1B58F39Q38992678-02CF0CCE-F4C6-4AF1-992D-5969443D07CBQ42473672-F4BAAB5E-0BA5-4669-BBD4-7A40D029E91FQ47352451-923D4DB7-186A-492A-AE41-4E8C2775EEFBQ47590580-350B343D-CD3A-48EB-A73C-0600F7B132BDQ48521617-1CB5474A-D27C-4D9C-8B75-F238575F86E0Q50530547-B16E5B3A-8751-42CE-8BF0-B2A22E071DB3Q55472927-481E521D-4745-4561-B96D-3EFBC30BFF3CQ58122056-38ADD974-EFE4-4724-A196-56044765E1DF
P2860
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@ast
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@en
type
label
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@ast
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@en
prefLabel
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@ast
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@en
P2093
P2860
P1433
P1476
A TLR2 agonist is a more effec ...... o other TLR and NOD receptors.
@en
P2093
Chunmei Cheng
Delia Tifrea
Ilham Bettahi
Luis M de la Maza
Pooja Jain
Sukumar Pal
P2860
P304
P356
10.1016/J.VACCINE.2011.06.105
P407
P577
2011-07-08T00:00:00Z